Skip to main content
. Author manuscript; available in PMC: 2013 Apr 22.
Published in final edited form as: Vasc Med. 2012 Apr;17(2):101–107. doi: 10.1177/1358863X12440117

Table 3.

Effects of Sulfasalazine on Biochemical Profile

Blood Marker Before Sulfasalazine After Sulfasalazine Before Placebo After Placebo P*
Total Cholesterol (mg/dl) 157±37 166±37 159±38 162±35 0.25
LDL Cholesterol (mg/dl) 81±30 94±31 83±34 89±29 0.09
HDL Cholesterol (mg/dl) 41±8 42±7 43±9 42±8 0.98
Triglycerides (mg/dl) 171±111 151±66 167±105 164±114 0.48
Glucose (mg/dl) 123±60 128±68 131±62 129±56 0.80
Insulin (μIU/dl) 13.0±8.1 10.7±5.0 13.2±9.3 11.9±5.4 0.25
HOMA-IR(au) 3.9±2.6 3.3±1.9 4.5±4.1 3.8±2.5 0.18
C-reactive protein (mg/L) 5.4±13.2 5.2±10.9 3.5±6.3 2.3±1.9 0.16
P-selectin 56±11 53±13 59±19 55±14 0.44
Interleukin-6 2.7±2.0 2.6±1.8 2.5±1.5 2.6±2.0 0.99
MCP-1 365±120 374±139 375±113 366±115 0.58
Soluble-ICAM-1 272±72 283±82 293±84 281±90 0.85

Mean±SD.

*

P value for paired t-test comparing after sulfasalazine to after placebo HOMA-IR = Homeostasis model assessment of insulin resistance; ICAM-1 = intercellular adhesion molecule-1.